Kholoud has worked in HIV since 1986 and with the MRC since 1994 leading an epidemiology programme of work in HIV research in the unit. She gained an MSc in Medical Statistics at the London School of Hygiene and Tropical Medicine and a PhD in AIDS and HIV Infection at University College London, where she is Professor of Epidemiology.
Her main research interests are in HIV natural history and primary HIV infection. Most of her work has been within industrialised country cohorts although she has also co-ordinated randomised controlled trials recruiting in Uganda and South Africa and within an international consortium evaluating antiretroviral therapy roll-out programmes in Africa. She is Project Leader for the UK Register of HIV Seroconverters and CASCADE, an EU-funded collaboration of HIV seroconverter cohorts. CASCADE is now part of a large Network of Excellence, EuroCoord, which she also leads.
Kholoud has collaborated widely within the UK, most notably UCL, Imperial, and LSHTM, and internationally with colleagues in European, Australian and north American research institutions. Aside from editorial work for AIDS, BMC Public Health, the Open AIDS Journal and Osong Public Health and Research Perspectives, she is a regular reviewer for several medical journals and abstracts for the International AIDS Society conferences. She has also presented at numerous national and international conferences.
Jaffe H, De Stavola B, Carpenter L, Porter K and Cox D. Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults. AIDS 2011; 25:1395-1403.
Lodi S, Phillips A, Touloumi G, Geskus R, Meyer L, Thiébaut R, Pantazis N, del Amo J, Johnson A M, Babiker A, Porter K on behalf of the CASCADE Collaboration in EuroCoord. Time from HIV seroconversion to reaching CD4 thresholds <200, <350 and <500 cells/mm3; assessment of need following changes in treatment guidelines. Clin Infec Dis 2011;53:817-825.
Funk MJ, Fusco J, Cole S, Davidian M, Thomas J, Kaufman J, White A, Hartmann K, Porter K, Eron J. Timing of HAART initiation and clinical outcomes HIV-1 seroconverters. Arch Intern Med 2011;171:1560-9.
Lodi S, Guiguet M, Costagliola D, Fisher M, de Luca A, Porter K and the CASCADE Collaboration. Incidence of Kaposi's Sarcoma and survival following its diagnosis in HIV-infected homosexual men followed up since HIV seroconversion. J Natl Cancer Inst 2010 102:784-92.
Bhaskaran K, Hamouda O, Sannes M, Boufassa F, Johnson A, Lambert P and Porter K on behalf of the CASCADE Collaboration. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA 2008; 2;300:51-9.